The Mumbai based leading pharmaceutical company Ipca Laboratories has received US FDA marketing approval for metoclopramide tablets DSP 5mg and 10mg. Ipca is marketing this product in alliance with Ranbaxy Pharmaceutical Ltd, a US subsidiary of Ranbaxy Laboratories.
The total annual market sales for metoclopramide tablets in US were US $27 millions. This is the sixth such product approval received under the alliance from US FDA.
The details can be read here.
No comments:
Post a Comment